亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年
搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:陳
  • 電話:19150309904
  • 郵件:aileen@youngshechem.com
  • 微信:19150309904
  • QQ:1398029096
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 肉豆蔻酰四肽-12/959610-24-3睫毛肽
肉豆蔻酰四肽-12/959610-24-3睫毛肽
單價 10.00 / g對比
銷量 暫無
發貨 四川成都市付款后3天內
庫存 1000g起訂1g
品牌 成都云希
CAS號 959610-24-3
外觀 白色粉末
功效 睫毛增長
過期 長期有效
更新 2021-07-05 16:42
 
詳細信息

肉豆蔻酰四肽-12/959610-24-3 /MyristoylTetrapeptide-12

肉豆蔻酰四肽-12/959610-24-3 /MyristoylTetrapeptide-12

中文:肉豆蔻酰四肽-12

INCI:Myristoyl Tetrapeptide-12

CAS號:959610-24-3

多肽結構:MYR-KKAA

分子式:C31H61N5O5

分子量:567.1

純度:95%

級別:化妝品級

包裝規格(粉末):500mg/瓶,1g/瓶;5g/瓶;10g/瓶;100g/瓶

肉豆蔻酰四肽-12是 一種可以促進睫毛生長的活性肽。

云希專業研發美容多肽原料,現有藍銅肽、二勝肽、三勝肽、四勝肽、五勝肽、六勝肽、七勝肽、八勝肽、九勝肽、十勝肽和寡肽系列等100多種美容活性勝肽,是國內、質量可靠的美容肽供應商。因為專業,所以更好!

©2025 成都云?;び邢薰?版權所有   技術支持:化工網   訪問量:41633  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |